EUVIMEDEUVIMED entdecken
Crossref

Repigmentation in non-segmental vitiligo using the Janus kinase inhibitor upadacitinib, a retrospective case series

Jing Zhu, Lingling Luo, Youming Guo, Tianqi Wei, Xin Huang, Xuemin Xiao, Chengrang Li

Archives of Dermatological Research · 20.12.2024 · 317 (1)

DOI: 10.1007/s00403-024-03658-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, online erschienen am 20.12.2024. Verfasst von Jing Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, No.12 Jiangwangmiao, Xuanwu…. Hauptthemen laut MEDLINE: Vitiligo, Janus Kinase Inhibitors, Heterocyclic Compounds, 3-Ring, Skin Pigmentation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: the Natural Science Foundation of Jiangsu province, CAMS Innovation Fund for Medical Sciences (CIFMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoJanus Kinase InhibitorsHeterocyclic Compounds, 3-RingSkin PigmentationHumansRetrospective StudiesMaleFemaleAdultTreatment OutcomeMiddle AgedJanus Kinase 1Severity of Illness IndexYoung AdultChemokine CXCL10

Stichwörter der Autor:innen

JAK inhibitorsRepigmentationUpadacitinibVitiligo

Substanzen

upadacitinibJanus Kinase InhibitorsHeterocyclic Compounds, 3-RingJanus Kinase 1Chemokine CXCL10CXCL10 protein, human

Autor:innen und Institutionen

  • Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, No.12 Jiangwangmiao, Xuanwu District, Nanjing, 210042, Jiangsu, China.
  • Department of Dermatology, The Union Hospital-Fujian Medical University, Fuzhou, China.
  • Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, No.12 Jiangwangmiao, Xuanwu District, Nanjing, 210042, Jiangsu, China. dr_lcr72@163.com.

Förderung

  • the Natural Science Foundation of Jiangsu province
  • CAMS Innovation Fund for Medical Sciences (CIFMS)

Zitieren

APA

Zhu, J., Luo, L., Guo, Y., Wei, T., Huang, X., Xiao, X., & Li, C. (2024). Repigmentation in non-segmental vitiligo using the Janus kinase inhibitor upadacitinib, a retrospective case series. Archives of Dermatological Research, 317(1). https://doi.org/10.1007/s00403-024-03658-x

Vancouver

Zhu J, Luo L, Guo Y, Wei T, Huang X, Xiao X, et al. Repigmentation in non-segmental vitiligo using the Janus kinase inhibitor upadacitinib, a retrospective case series. Archives of Dermatological Research. 2024;317(1). doi:10.1007/s00403-024-03658-x

BibTeX
@article{Zhu2024,
  author = {Zhu, Jing and Luo, Lingling and Guo, Youming and Wei, Tianqi and Huang, Xin and Xiao, Xuemin and Li, Chengrang},
  title = {Repigmentation in non-segmental vitiligo using the Janus kinase inhibitor upadacitinib, a retrospective case series},
  journal = {Archives of Dermatological Research},
  year = {2024},
  volume = {317},
  number = {1},
  doi = {10.1007/s00403-024-03658-x}
}
Kostenlos starten →